Overview
Qualitative or quantitative defects of nebulin (Orphanet code 209182) refers to a group of conditions caused by mutations in the NEB gene, which encodes nebulin, a giant structural protein essential for the proper assembly and function of thin filaments in skeletal muscle. Nebulin plays a critical role in regulating actin filament length, muscle contraction, and sarcomere stability. Defects in nebulin — whether the protein is reduced in quantity, absent, or structurally abnormal — are the most common cause of autosomal recessive nemaline myopathy (NM), particularly the typical congenital form. These defects primarily affect the skeletal muscular system. Patients with nebulin-related myopathies typically present with generalized muscle weakness, hypotonia (reduced muscle tone), feeding difficulties, and respiratory insufficiency, often apparent from birth or early infancy. Facial weakness, a high-arched palate, and a thin body habitus are common features. Severity is variable, ranging from severe neonatal forms with profound weakness and respiratory failure to milder childhood-onset forms with slowly progressive or relatively stable weakness. Muscle biopsy characteristically shows nemaline bodies (rod-shaped structures) within muscle fibers, though other histological patterns such as core-rod myopathy or fiber-type disproportion may also be seen. There is currently no cure or disease-specific therapy for nebulin-related myopathies. Management is supportive and multidisciplinary, focusing on respiratory support (including non-invasive ventilation), nutritional optimization, physical therapy, orthopedic management of scoliosis and joint contractures, and monitoring for cardiac complications, although cardiac involvement is uncommon. Research into gene therapy and other molecular approaches is ongoing but remains in early stages. Early intervention and coordinated care can significantly improve quality of life and functional outcomes.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Qualitative or quantitative defects of nebulin.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Qualitative or quantitative defects of nebulin at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Qualitative or quantitative defects of nebulin.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Qualitative or quantitative defects of nebulin.
Community
No community posts yet. Be the first to share your experience with Qualitative or quantitative defects of nebulin.
Start the conversation →Latest news about Qualitative or quantitative defects of nebulin
No recent news articles for Qualitative or quantitative defects of nebulin.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Qualitative or quantitative defects of nebulin
What is Qualitative or quantitative defects of nebulin?
Qualitative or quantitative defects of nebulin (Orphanet code 209182) refers to a group of conditions caused by mutations in the NEB gene, which encodes nebulin, a giant structural protein essential for the proper assembly and function of thin filaments in skeletal muscle. Nebulin plays a critical role in regulating actin filament length, muscle contraction, and sarcomere stability. Defects in nebulin — whether the protein is reduced in quantity, absent, or structurally abnormal — are the most common cause of autosomal recessive nemaline myopathy (NM), particularly the typical congenital form.
How is Qualitative or quantitative defects of nebulin inherited?
Qualitative or quantitative defects of nebulin follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Qualitative or quantitative defects of nebulin typically begin?
Typical onset of Qualitative or quantitative defects of nebulin is neonatal. Age of onset can vary across affected individuals.